Skip to Content
Print Save

93-6 (Naproxen Delayed Release 500 mg)

Pill with imprint 93-6 is White, Elliptical / Oval and has been identified as Naproxen Delayed Release 500 mg. It is supplied by Teva Pharmaceuticals USA.

Naproxen is used in the treatment of back pain; bursitis; ankylosing spondylitis; neck pain; tendonitis and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Risk cannot be ruled out during pregnancy. Naproxen 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93-6

Naproxen delayed release 500 mg 93-6
Naproxen delayed release 500 mg 93-6
Naproxen delayed release 500 mg 93-6 Front
Naproxen delayed release 500 mg 93-6 Back
Naproxen delayed release 500 mg 93-6

Naproxen Delayed Release

Imprint
93-6
Strength
500 mg
Color
White
Size
16.00 mm
Shape
Elliptical / Oval
Availability
Rx and/or OTC
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
corn starch, croscarmellose sodium, FD&C Blue No. 2, indigotindisulfonate sodium, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, povidone k90, propylene glycol, shellac, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-1006 Teva Pharmaceuticals USA, Inc.
63874-0984 Altura Pharmaceuticals Inc. (repackager)
55289-0307 PDRX Pharmaceuticals Inc. (repackager)
More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "93-6"

Clindamycin Hydrochloride
Quetiapine Fumarate
Fosamax

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer